PHARMA

0.305

(%)

Change in Principal Officer

PHARMANIAGA BERHAD

Date of change 08 Mar 2024
Name ENCIK MOHAMED IQBAL ABDUL RAHMAN
Age 60
Gender Male
Nationality Malaysia
Type of change Retirement
Designation Chief Operating Officer

Qualifications

No
Qualifications
Major/Field of Study
Institute/University
Additional Information
Degree
Bachelor in Computer Science
Universiti Putra Malaysia
  
Working experience and occupation
Encik Mohamed Iqbal joined Pharmaniaga in 2011 as Director of Information Technology before promoted to Chief Operating Officer in 2012. With more than 32 years of experience, mainly in System Improvement & Operations Management, he spearheaded the implementation of the Business Intelligence System and Robotic Process Automation, and played a vital role in the implementation of the Pharmacy Information System ("PhIS") to over 1,200 Ministry of Health ("MOH") facilities.

On 1 April 2020, he was appointed as Acting Managing Director and subsequently appointed as Deputy Managing Director on 1 September in the same year. He was also serving as Commissioner of PT. Millennium Pharmacon International Tbk. ("MPI") between 2012 to 2021. During the pandemic, Encik Mohamed Iqbal was responsible for leading a team to successfully implement fill and finish manufacturing of the
Sinovac Covid-19 vaccine. In 2023, Encik Mohamed Iqbal led a team to a successful negotiation of the new concession agreement with MOH.

Prior to joining Pharmaniaga, Encik Mohamed Iqbal was the General Manager - Head of Operations in Faber Medi-Serve Sdn Bhd, a provider of hospital support services. He was responsible for the companys overall operations whilst overseeing all the regional offices, plants and hospitals within the Concession. He was also the key liaison person, leading all the stakeholder engagement activities with MOH.

A Bachelor of Computer Science degree holder from University Putra Malaysia, Encik Mohamed Iqbal is a strong believer in fit for purpose technology and cost improvement. His experience and leadership have been focused on developing and delivering technology-driven business solutions, providing outstanding client service, and driving profitable revenue growth.
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Nil



Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 08 Mar 2024
Category Change in Principal Officer
Reference Number C04-06032024-00001